Publications by authors named "Sarah Francini"
Article Synopsis
- * CTCs were found primarily in the ovarian vein samples of 8 out of 10 patients, with no significant differences in the number of CTCs based on age, tumor grade, FIGO stage, or tumor size.
- * The study identified estrogen receptor-positive CTCs and clusters, indicating a need for further research on the potential prognostic and therapeutic implications of CTCs during EC surgery.
Long-term quality of life after surgical Essure removal for device-attributed symptoms.
Eur J Obstet Gynecol Reprod Biol
January 2023
Article Synopsis
- The study looked at how patients felt after having their Essure devices surgically removed, checking their quality of life (QoL) and any symptoms they had before and after the surgery.
- 65 patients had the surgery, and while many felt better after 3 months and 4 years, some still had problems or didn't improve at all.
- The researchers found that mental health issues like anxiety were more common before the surgery but improved afterwards; they suggest more research to fully understand the risks and benefits of this surgery.
Essure removal for device-attributed symptoms: Quality of life evaluation before and after surgical removal.
J Gynecol Obstet Hum Reprod
February 2021
Article Synopsis
- * Included 95 women, who underwent various surgical procedures, and QoL was assessed using SF-36 questionnaires both before and three months after the surgery.
- * Results showed significant improvements in both physical and mental health scores post-surgery, indicating that most patients experienced a better quality of life three months after the removal procedure.
Background: Essure is an effective method for hysteroscopic sterilization. Reports of adverse effects, the underlying mechanisms of which are unknown, have increased in recent years.
Objective: The aim of the study was to determine whether there is a relationship between adverse events attributed to Essure and nickel sensitization.
Study Objective: To evaluate the feasibility, efficacy, and morbidity of Essure® device removal via laparoscopic en bloc salpingectomy-cornuectomy resection (LSC) and the utility of confirmation of complete removal with an intraoperative X-ray of the removed specimen (IX-S).
Design: Retrospective observational cohort study.
Setting: Academic hospitals of La Conception, Marseille, and Arnaud-de-Villeneuve, Montpellier, France.